Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa

Verfasser / Beitragende:
[Ali Bahar, Zhigang Liu, Filbert Totsingan, Carlos Buitrago, Neville Kallenbach, Dacheng Ren]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/19(2015-10-01), 8125-8135
Format:
Artikel (online)
ID: 60549889X
LEADER caa a22 4500
001 60549889X
003 CHVBK
005 20210128100548.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6645-7  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6645-7 
245 0 0 |a Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa  |h [Elektronische Daten]  |c [Ali Bahar, Zhigang Liu, Filbert Totsingan, Carlos Buitrago, Neville Kallenbach, Dacheng Ren] 
520 3 |a Antimicrobial dendrimeric peptides (AMDP) are a relatively new class of agents displaying repetitive functional groups on a branched core. Previously, we have investigated the length requirement for antimicrobial activity of peptides consisting of repeated arginine (R) and tryptophan (W) side chains and found that even short linear RW repeats are active, providing a starting point for a de novo design of multivalent structures. In this study, we synthesized and tested a new synthetic dendrimer, 2D-24, for its antimicrobial activity against Pseudomonas aeruginosa, including the wild-type PAO1 and its mucoid mutant PDO300. This synthetic AMDP was found to kill planktonic cells of both PAO1 and PDO300 in a dose-dependent manner, with nearly complete killing of both strains observed when treated with 50μM of this agent. In addition to planktonic cells, 2D-24 was also found to kill biofilm cells of both strains in a dose-dependent manner. For example, treatment with 30μM 2D-24 led to 94.4 ± 1.4 and 93.9 ± 4.2% killing of PAO1 and PDO300 biofilm cells, respectively. Furthermore, 2D-24 was effective in killing multidrug-tolerant persister cells of PAO1 and PDO300. While higher concentrations of 2D-24 were required to kill persister cells, combinations of 2D-24 with ciprofloxacin, tobramycin, or carbenicillin showed synergistic effects on killing persister cells of both strains. Based on hemolysis assays using sheep erythrocytes and a coculture model of PAO1 and human epithelial cells, 2D-24 was found to kill P. aeruginosa cells at concentrations that are not toxic to mammalian cells. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Pseudomonas aeruginosa  |2 nationallicence 
690 7 |a Antimicrobial peptide  |2 nationallicence 
690 7 |a Biofilm  |2 nationallicence 
690 7 |a Persister cells  |2 nationallicence 
690 7 |a Killing  |2 nationallicence 
700 1 |a Bahar  |D Ali  |u Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY, USA  |4 aut 
700 1 |a Liu  |D Zhigang  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
700 1 |a Totsingan  |D Filbert  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
700 1 |a Buitrago  |D Carlos  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
700 1 |a Kallenbach  |D Neville  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
700 1 |a Ren  |D Dacheng  |u Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY, USA  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/19(2015-10-01), 8125-8135  |x 0175-7598  |q 99:19<8125  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6645-7  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6645-7  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bahar  |D Ali  |u Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Liu  |D Zhigang  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Totsingan  |D Filbert  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Buitrago  |D Carlos  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kallenbach  |D Neville  |u Department of Chemistry, New York University, New York, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ren  |D Dacheng  |u Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/19(2015-10-01), 8125-8135  |x 0175-7598  |q 99:19<8125  |1 2015  |2 99  |o 253